Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Revenue:        
Revenue $ 98,023 $ 103,315 $ 257,149 $ 314,734
Cost of revenue:        
Cost of revenue 55,744 56,239 145,284 178,309
Gross profit 42,279 47,076 111,865 136,425
Operating expenses:        
Research and development 9,589 9,325 29,983 27,058
Sales and marketing 15,294 15,421 40,019 46,101
General and administrative 11,103 10,719 32,928 43,623
Restructuring charges 200 (64) 2,837 1,020
Total operating expenses 36,186 35,401 105,767 117,802
Income from operations 6,093 11,675 6,098 18,623
Other expense, net (698) (611) (1,395) (446)
Interest expense (7,808) (6,425) (21,823) (19,079)
Net income (loss) before income taxes (2,413) 4,639 (17,120) (902)
Income tax provision (benefit) 256 (110) 877 471
Net income (loss) $ (2,669) $ 4,749 $ (17,997) $ (1,373)
Net income (loss) per share - basic (in dollars per share) $ (0.07) $ 0.12 $ (0.45) $ (0.04)
Net income (loss) per share - diluted (in dollars per share) $ (0.07) $ 0.10 $ (0.45) $ (0.04)
Weighted average shares - basic (in shares) 40,927 38,134 40,374 36,828
Weighted average shares - diluted (in shares) 40,927 46,567 40,374 36,828
Foreign currency translation adjustments, net $ 975 $ 839 $ 1,984 $ 449
Total comprehensive income (loss) (1,694) 5,588 (16,013) (924)
Product        
Revenue:        
Revenue 63,021 66,435 153,557 200,361
Cost of revenue:        
Cost of revenue 43,311 43,672 108,691 140,337
Service        
Revenue:        
Revenue 31,169 32,892 93,049 98,673
Cost of revenue:        
Cost of revenue 12,433 12,567 36,593 37,972
Royalty        
Revenue:        
Revenue $ 3,833 $ 3,988 $ 10,543 $ 15,700